The clinical characteristics, mechanism and prevention of gastrointestinal perforation due to bevacizumab

PDF(593 KB)
PDF(593 KB)
Adverse Drug Reactions Journal ›› 2015, Vol. 17 ›› Issue (6) : 449-452.

The clinical characteristics, mechanism and prevention of gastrointestinal perforation due to bevacizumab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2015, 17(6): 449-452

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(593 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉